Downloads - The Reaction Project

Affiliations

REACTION is affilliated with these programs and organisations:

REACTION is delivering better and more efficient healthcare services in Europe, thus supporting the Commissions activities in ICT for Health: eHealth.

The REACTION platform allows for the creation of inclusive applications with accessibility for all. The project supports the Commissions campaign: eInclusion - be part of it!

Sign In

Forgot Password?

The REACTION project is a 4-year project started in 2010. It is partly funded by the European Commission under the 7th Framework Programme in the area of Personal Health Systems under Grant Agreement no. 248590

Impressum

Privacy

Newsletters

Read previous issues of our newsletter here:
April 2014
August 2013
June 2012
August 2011
April 2011
November 2010

Most Read...

Articles

In-hospital saf...	186507
Reaction in the...	113426
Medical background	106242
Project overview	105775
Project methodo...	79767

News

Research award ...	57610
IST-Africa Call...	54539
REACTION at one...	52528
REACTION videos...	49522
REACTION online...	47905

Popular Downloads

REACTION brochure	30251
Design of a mobil...	13067
D9-4 Healthcare e...	11224
D9-2 Regulatory f...	10083
2_Regulatory Fram...	6606

Facebook

Join the discussion on EC eHealth at Facebook!

Oh no! Where's the JavaScript?
Your Web browser does not have JavaScript enabled or does not support JavaScript. Please enable JavaScript on your Web browser to properly view this Web site, or upgrade to a Web browser that does support JavaScript.

Downloads: D8.1 Clinical protocol for MDI compliance

Downloads Home > Deliverables > D8.1 Clinical protocol for MDI compliance

D8.1 Clinical protocol for MDI compliance 3

The objectives of this deliverable are to:

1. Establish a compliance monitoring application for MDI (Multiple Daily Injection) insulin pens therapy and assess its impact on the patient’s clinical pathway.
2. To establish a compliance monitoring program using a medication dispenser in order to determine its impact on the patient’s clinical pathway.

Or in the event that the insulin pen is not available due to Novo Nordisk not joining the project then:

3. Establish compliance monitoring using manual recording of time and dose of the insulin injection and the patient will be instructed to use the smart phone (or similar user terminal) to send the data to the REACTION platform and assess its impact on the patient’s clinical pathway.